OssDsign AB (publ) (OSSD.ST)
SEK 10.08
(0.4%)
SEK 10.08
(0.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 356.38 Million SEK | 12.03% |
| 2022 | 318.12 Million SEK | -7.52% |
| 2021 | 343.98 Million SEK | 39.46% |
| 2020 | 246.65 Million SEK | 60.93% |
| 2019 | 153.26 Million SEK | 104.03% |
| 2018 | 75.12 Million SEK | 7.04% |
| 2017 | 70.18 Million SEK | 81.69% |
| 2016 | 38.62 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 313.87 Million SEK | -11.93% |
| 2024 Q2 | 306.45 Million SEK | -2.36% |
| 2023 Q4 | 356.38 Million SEK | 5.89% |
| 2023 Q2 | 266.28 Million SEK | -7.77% |
| 2023 FY | 356.38 Million SEK | 12.03% |
| 2023 Q1 | 288.72 Million SEK | -9.24% |
| 2023 Q3 | 336.57 Million SEK | 26.4% |
| 2022 Q4 | 318.12 Million SEK | 13.31% |
| 2022 Q2 | 300.25 Million SEK | -5.99% |
| 2022 FY | 318.12 Million SEK | -7.52% |
| 2022 Q1 | 319.39 Million SEK | -7.15% |
| 2022 Q3 | 280.74 Million SEK | -6.5% |
| 2021 Q3 | 391.48 Million SEK | -13.73% |
| 2021 FY | 343.98 Million SEK | 39.46% |
| 2021 Q4 | 343.98 Million SEK | -12.13% |
| 2021 Q2 | 453.81 Million SEK | 103.66% |
| 2021 Q1 | 222.82 Million SEK | -9.66% |
| 2020 Q2 | 120.7 Million SEK | -9.03% |
| 2020 FY | 246.65 Million SEK | 60.93% |
| 2020 Q3 | 108.24 Million SEK | -10.32% |
| 2020 Q1 | 132.69 Million SEK | -13.43% |
| 2020 Q4 | 246.65 Million SEK | 127.87% |
| 2019 Q3 | 178.86 Million SEK | -10.49% |
| 2019 Q1 | 82.84 Million SEK | 10.28% |
| 2019 FY | 153.26 Million SEK | 104.03% |
| 2019 Q4 | 153.26 Million SEK | -14.31% |
| 2019 Q2 | 199.82 Million SEK | 141.2% |
| 2018 FY | 75.12 Million SEK | 7.04% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 Q4 | 75.12 Million SEK | 0.0% |
| 2017 FY | 70.18 Million SEK | 81.69% |
| 2016 FY | 38.62 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -466.74% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 89.159% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 89.159% |
| Arcoma AB | 81.96 Million SEK | -334.822% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 47.811% |
| BICO Group AB (publ) | 10.19 Billion SEK | 96.505% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 52.802% |
| CellaVision AB (publ) | 928.71 Million SEK | 61.625% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -517.391% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -1523.235% |
| C-Rad AB (publ) | 404 Million SEK | 11.785% |
| Duearity AB (publ) | 15.14 Million SEK | -2253.335% |
| Dignitana AB (publ) | 44.83 Million SEK | -694.961% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -241.696% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.353% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -247.228% |
| Iconovo AB (publ) | 128.07 Million SEK | -178.255% |
| Integrum AB (publ) | 164.85 Million SEK | -116.178% |
| Luxbright AB (publ) | 40.68 Million SEK | -775.936% |
| Mentice AB (publ) | 322.52 Million SEK | -10.499% |
| Paxman AB (publ) | 167.12 Million SEK | -113.247% |
| Promimic AB (publ) | 92.87 Million SEK | -283.73% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -812.741% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -453.967% |
| ScandiDos AB (publ) | 81.47 Million SEK | -337.432% |
| Sectra AB (publ) | 3.21 Billion SEK | 88.901% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 64.855% |
| Senzime AB (publ) | 433.54 Million SEK | 17.796% |
| SpectraCure AB (publ) | 144.83 Million SEK | -146.067% |
| Stille AB | 804.89 Million SEK | 55.722% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 97.826% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 83.768% |